Upgrade to SI Premium - Free Trial

Needham Downgrades Amphastar Pharmaceuticals (AMPH) to Hold

May 8, 2026 7:10 AM
Needham analyst Serge Belanger downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades